A Minnesota doctor is seeking 1500 volunteers for the first trial, but in the week since he obtained FDA approval, has managed to recruit only 411. Recruitment for the second trial is going even slower.
March 25, 2020, 8:30 PMEarly cases of COVID-19 are believed to be linked to a live-animal market in Wuhan, China.
The first trial will be comprised primarily of healthcare workers and others with a high risk of exposure to the virus, while the second will be open to the general public who have already tested positive for COVID-19. Hydroxychloroquine is being studied both as a way to prevent COVID-19 infection as well as a way to treat people who are already sick.
“With all the excitement about the Hydroxychloroquine, there’s no actual data that it makes any clinical benefit in actual humans,” Boulware told ABC News. “We’re going to test whether it reduces the severity of symptoms, reduces hospitalizations, and severity and duration of illness to see – Does the drug actually work? And is it safe?”Medical staff shows tablets containing hydroxychloroquine, Feb. 26, 2020.
México Últimas Noticias, México Titulares
Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.
Doctors are reportedly hoarding trial coronavirus drugs for themselves - Business InsiderThe drugs are usually used to treat illnesses like HIV and malaria, and are not approved by the FDA to treat the coronavirus.
Leer más »
FDA will allow doctors to treat critically ill coronavirus patients with blood from survivorsUnder new emergency protocols approved Tuesday, FDA will allow doctors across the US to begin using plasma donated by coronavirus survivors to treat patients who are critically ill with the virus.
Leer más »
Chloroquine treats malaria: Will it work against coronavirus? The side effects are risky, experts sayTwo malaria drugs, chloroquine and hydroxychloroquine, are being studied as a possible treatment for COVID-19. Scientists warn the drugs are untested
Leer más »
FDA Approved Drugs Show Promise Against COVID-19Two promising new studies suggest that dozens of drugs already approved for use in the United States may prove effective against the new coronavirus.
Leer más »
FDA Approves Plasma Treatment for Coronavirus on Conditional BasisThe blood plasma of patients who have recovered from Covid-19 will be allowed for conditional use in treating the disease even though the effectiveness is unproven.
Leer más »
FDA Approves More ‘Rapid’ COVID-19 Coronavirus Tests For Use On FrontlinesThe U. S. Food and Drug Administration is approving more rapid molecular diagnostic tests that can be used in temporary screening locations, doctor’s office labs and nursing homes to detect the Coronavirus strain COVID-19 in less than a half hour.
Leer más »